COVID-19 and dialysis: why we should be worried
G Rombola, F Brunini - Journal of Nephrology, 2020 - Springer
In the last 6 months, starting from China and the Eastern Countries and spreading to Europe
and the United States, a new strand of Coronavirus, SARS-CoV-2, is challenging healthcare …
and the United States, a new strand of Coronavirus, SARS-CoV-2, is challenging healthcare …
COVID-19 in dialysis patients: outlasting and outsmarting a pandemic
CM Hsu, DE Weiner - Kidney international, 2020 - Elsevier
Coronavirus disease 2019 (COVID-19) has affected the care and outcomes of patients
treated with dialysis worldwide. In this issue of Kidney International, 3 reports highlight the …
treated with dialysis worldwide. In this issue of Kidney International, 3 reports highlight the …
Results from the IRoc-GN international registry of patients with COVID-19 and glomerular disease suggest close monitoring
M Waldman, MJ Soler, C García-Carro, L Lightstone… - Kidney international, 2021 - Elsevier
The effects of SARS-CoV-2 infection on individuals with immune-mediated
glomerulonephritis, who are often undergoing immunosuppressive treatments, are …
glomerulonephritis, who are often undergoing immunosuppressive treatments, are …
Recommendations for the use of COVID-19 vaccines in patients with immune-mediated kidney diseases
A Kronbichler, HJ Anders… - Nephrology Dialysis …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19) vaccine platforms are becoming available
and are the most promising strategy to curb the spread of severe acute respiratory syndrome …
and are the most promising strategy to curb the spread of severe acute respiratory syndrome …
[HTML][HTML] Efficacy of anti–SARS-CoV-2 monoclonal antibody prophylaxis and vaccination on the Omicron variant of COVID-19 in kidney transplant recipients
D Bertrand, C Laurent, V Lemée, L Lebourg… - Kidney …, 2022 - ncbi.nlm.nih.gov
To the editor: Solid organ transplantation (SOT) recipients are at very high risk of developing
severe coronavirus disease 2019 (COVID-19). 1 Despite the implementation of a third dose …
severe coronavirus disease 2019 (COVID-19). 1 Despite the implementation of a third dose …
The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or …
JSF Sanders, FJ Bemelman, AL Messchendorp… - …, 2022 - journals.lww.com
Background. In kidney patients COVID-19 is associated with severely increased morbidity
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of …
Increased 1-year mortality in haemodialysis patients with COVID-19: a prospective, observational study
S Carriazo, S Mas-Fontao, C Seghers… - Clinical Kidney …, 2022 - academic.oup.com
Background Dialysis confers the highest risk of coronavirus disease 2019 (COVID-19) death
among comorbidities predisposing to severe COVID-19. However, reports of COVID-19 …
among comorbidities predisposing to severe COVID-19. However, reports of COVID-19 …